Why does tesamorelin burn?
The label lists injection site reactions, including pain, irritation and erythema, which affected 25% of treated patients versus 14% on placebo in the first 26 weeks.
GHRH analogUpdated
Short answer
The label lists injection site reactions, including pain, irritation and erythema, which affected 25% of treated patients versus 14% on placebo in the first 26 weeks.[1]
What the label lists
The label names the reactions as erythema, pruritus, pain, irritation and bruising.[1]
Injection site erythema and pruritus are among the most commonly reported adverse reactions.[1]
The label separately lists hypersensitivity reactions as a warning and says to stop treatment if one is suspected.[1]
More questions on Tesamorelin
More on Tesamorelin
Sources
- 1EGRIFTA SV prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
Found an error? Report a correction.